1.
Evaluation of anemia and serum iPTH, calcium, and phosphorus in patients with primary glomerulonephritis.
Li, Y, Zhang, W, Ren, H, Wang, W, Shi, H, Li, X, Chen, X, Shen, P, Wu, X, Xie, J, et al
Contributions to nephrology. 2013;:31-40
Abstract
Glomerulonephritis (GN) remains a major cause of morbidity and mortality in chronic kidney disease (CKD). Our study aimed to investigate the prevalence of anemia, abnormal serum intact parathyroid hormone (iPTH), calcium, and phosphorus in a Chinese patient population with primary GN. Medical histories and laboratory test results were collected from 2,924 patients with primary GN hospitalized in Ruijin Hospital of Shanghai between January 2003 and August 2009. The leading cause of CKD was primary glomerular diseases, which were responsible for up to 53.5% of all cases. IgA nephropathy was the most common cause, accounting for 38.7%, followed by focal segmental glomerulosclerosis (FSGS). The anemia rate of GN patients in early stages of CKD (stages 1-2 and 3) was 16-36%, and rapidly accelerated to 65.8 and 80.2% in advanced CKD stage 4 and stage 5, respectively. There was no significant decline observed in the level of serum calcium in patients with CKD stages 1-4 (p > 0.05). However, in patients with CKD stage 5 the prevalence of hypocalcaemia increased significantly (13.7%, p = 0.000). The prevalence of hyperphosphatemia did not significantly increase in patients with CKD stages 1-3 (p < 0.05), but was much higher in patients with CKD stages 4 and 5 (p = 0.001 and p = 0.021, respectively) and showed a negative correlation with renal function. Serum iPTH levels did not increase significantly in GN patients with CKD stages 1-2. The median iPTH levels were 54.7, 88.6, and 289.2 pg/ml (p = 0.000) for CKD stages 3-5, respectively, all of which showed negative correlation with renal function. The proportion of vitamin D insufficiency and deficiency increased to 29.3 and 11.2%, respectively, as the glomerular filtration rate fell below 15 ml/min/1.73 m(2). Primary glomerular disease remains the major cause of CKD in China, and complications such as anemia and metabolic bone disease are frequently present in GN patients.
2.
Bioengineering and management for efficient phosphorus utilization in crops and pastures.
Tian, J, Wang, X, Tong, Y, Chen, X, Liao, H
Current opinion in biotechnology. 2012;(6):866-71
Abstract
Phosphorus (P) is one of the three macronutrients for plants. Because of its low mobility and high fixation in soils, low P availability is a worldwide constraint for crop productivity. Molecular biology provides great opportunities to improve P efficiency in plants. However, transgenic plants cannot be commercialized before integrating all the knowledge on bottlenecks for improving P efficiency of crops/pastures. This review intends to summarize the main strategies of bioengineering to improve P efficiency of crops/pastures, including conventional and molecular assisted breeding, identification and application of key genes for biotech plants. It highlights recent advances in the understanding of improving P efficiency through the integration of bioengineering with P fertilization and cultivation management.
3.
Phosphorus dynamics: from soil to plant.
Shen, J, Yuan, L, Zhang, J, Li, H, Bai, Z, Chen, X, Zhang, W, Zhang, F
Plant physiology. 2011;(3):997-1005